Top 50 Life Science VC (Venture Capital) Funds in France in October 2023

Portfolio highlights

• Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
• Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
• Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.

Portfolio highlights

• Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
• Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
• Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.

Portfolio highlights

• Iktos — Iktos is the only company to offer generative modeling with built-in synthetic accessibility for successful drug discovery
• DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
• The Exploration Company — For Space & Non-Space Industries.

Portfolio highlights

• Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
• Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
• Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Portfolio highlights

• Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
• Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
• Anoat Therapeutics — Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

Portfolio highlights

• GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
• SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
• C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.

Portfolio highlights

• Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
• Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
• BreezoMeter — BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.

Portfolio highlights

• Wizaly — Optimize the ROI of your marketing mix based on our 100% data driven view of the performance of your marketing channels.Unlock the Power of Marketing Analytics at Wizaly.com: Optimize Your Marketing Campaigns, Maximize ROI, and Understand the Customer Journey. Discover actionable insights and data-driven strategies to drive your business forward. Start your journey to marketing success today!
• Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
• Germitec SAS — Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.

Portfolio highlights

• Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
• Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
• Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Portfolio highlights

• WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
• New School Foods — Whole-muscle, plant-based seafood
• Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.

Portfolio highlights

• DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
• smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
• Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.

Portfolio highlights

• Moximed — Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis.
• Tridek-One — Tridek-One is a private biotechnology company founded in 2018, based on groundbreaking research by our scientific founders at INSERM, Paris on the role of CD31 in the modulation of the immune response.
• PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.

Portfolio highlights

• Sereact — Discover the world's easiest pick-and-pack automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.
• Grasp — Grasp mission is to increase the rate at which humans learn.
• Amperecloud — ampere.cloud is Renewables & Environment company

Portfolio highlights

• MAJORITY — MAJORITY is the first digital financial service dedicated to serving migrants worldwide. For $5 a month, MAJORITY members in the U.S. receive an FDIC-secured account, VISA® debit card, use of more than 55,000 ATMs across North America, remittance and international calling, native language advisors, and access to our network of community meet-upspaces, local discounts and events. With MAJORITY, there are never overdraft fees or minimum balance requirements. MAJORITY was started in Sweden by a diverse team of banking, fintech, payments, and telecom executives serving immigrant communities globally for the last 15 years. MAJORITY’s U.S. headquarters are in Houston, Texas.
• Quell — An immersive first-person fitness game you can play anywhere - Quell is the future of fitness gaming.
• Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.

Portfolio highlights

• BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
• Erthos — erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
• ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport

Portfolio highlights

• GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
• Nous anti-gaspi — We anti-Gapsi is the network of anti-waste food stores. This grocery store project offers producers and manufacturers the opportunity to their downgraded and unsold products at a fair price. They are a qualitative environment, they market products excluded from the usual mass distribution circuits for small defects, physical defects, contract-datenot respected, and end of series. They offer consumers a new mode of consumption that gives priority to common sense and that is at the same time smart, qualitative, and eco-responsible. In their stores, they offer you to find, in a warm atmosphere, a complete choice of food products to save waste: fruits and vegetables, fresh and frozen products, groceries, and even a small bulk section.
• Peas&Love (Urban farm Company SA) — Our mission is to help cities to become greener, more sustainable, more human. By installing our farms, we provide eco-systemic services to cities, improving their quality of life and creating social interactions. We want to extent our farms, and from there become the urban farming glocal leader; delivering a positive and healthy experience thatwill dramatically improve our clients lives.

Portfolio highlights

• DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
• SAB Biotherapeutics — A biopharmaceutical development company leading the science and manufacturing of antibody therapeutics. Utilizing some of the most advanced antibody science in the world, SAB is delivering the world’s first large-scale platform to create immunoglobulins. This natural production platform holds the potential for treatment of public health problems,rare conditions, long-term diseases and global pandemic threats.
• Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.

Portfolio highlights

• CO2 AI — Empowering decision-makers to sustain our world via advanced software that shifts carbon emissions reduction from the theoretical to the impactful.
• UpSlide — Produce high-quality reports and presentations faster in PowerPoint, Excel and Word. Save up to 8h each month in just a few clicks!
• Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.

Portfolio highlights

• Blue Valet — Blue Valet is a provider of valet parking-parking at airports and train stations.
• Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
• Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

Portfolio highlights

• SILEANE — SILEANE is robotics, vision, and artificial intelligence. They offer to build machines to automate. They provide services that include robotique, vision industrielle, robotique adaptative, automatisation du geste, pick place, dévracage, traitement de surface, and intelligence artificielle.
• E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
• Monet Associes — Monet + Associes is a public relations agency.

Portfolio highlights

• Liberation Labs — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
• People Science — People Science offers data collection technology and services for clinical research studies of alternative medicines and wellness interventions.
• Pow.bio — Pow.bio provides fermentation services for synthetic biology.

Portfolio highlights

• GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
• Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
• SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.

Portfolio highlights

• Animaj — Explore the future of storytelling where AI meets creativity at Animaj Lab. Join us on a journey to revolutionize kids' entertainment, crafting captivating content that keeps the digital-first generation engaged and inspired.
• elba — elba is the ultimate experience to secure your team in their daily work.
• Smart Tribune — Smart-platform is a turnkey solution that allows a company / association / e-merchant to establish a conversational space directly with its user community. Present on the entire site of a company / association / e-merchant Smart Platform will enable to gather opinions, suggestions, problems, praise, and exploit them toimprove service, reduce cost of its customer service and increase its conversion rate. In the trend of Social CRM, Smart -tribune is based on a simple and intuitive interface for its users and allows great mastery thanks to an advertiser perspective administration interface. An effective way to better know your community, your customers in order to better the satisfy.

Portfolio highlights

• V7 — The world's best deep learning teams use V7's tools to create high-performing computer vision models.
• GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
• Sereact — Discover the world's easiest pick-and-pack automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.

Portfolio highlights

• Dianosic — Dianosic was founded in 2017 and develops innovative solutions in the field of ENT (Ear, Nose & Throat), a $50 billion, double digit growth, and still largely underserved market. Our startup operates right at the frontier between Medtech and Biotech, as we see tremendous opportunities for drug-device combinations in this specialty. The projectoriginates from the ENT Department from the University Hospital of Strasbourg, where unmet clinical needs have been identified. Our main focus areas are Chronic Rhinitis, Chronic Sinusitis and intranasal bleeding (Epistaxis). Noteworthy, Dianosic has a strong French and German footprint in R&D and manufacturing.Dianosic’s strategic goal is to establish new standards of care in Chronic Rhinitis and Chronic Sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This drug-device combination ARIS platform, developed with world renowned resorbable polymers experts, has the potential to establish new treatment paradigms. Moreover, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.Beside this, Dianosic commercialize an Asymmetric Intranasal inflatable solution (CAVI-T) for the treatment of intranasal bleeding, a widespread condition in ENT that affects 10% of the population. This CE marked and FDA registered technology addresses a clear unmet need and demonstrated our ability not only to develop a differentiated technology in record time, but also to successfully transition from R&D to Sales. We are currently present in relevant markets in EU and paving the way to launch in the U.S. in the mid term. Noteworthy, since our main call point is the ENT, CAVI-T prepares the ground for our upcoming ARIS platform.
• VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
• BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.

Portfolio highlights

• Bfore.AI — Starting from patented technology developed in years of research, BforeAi is the prediction service that looks for newly registered or morphed domains, and score their maliciousness looking at metadata and links to other bad guys.
• Exotrail — Exotrail is an end-to-end space mobility operator. Our mission is to enable small satellites to move in space, optimise their deployment, increase their service performance, and reduce space pollution.
• Look Up Space — Lookup space is the next global leader for space safety, security and sustainability

Portfolio highlights

• Naurex — Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs),which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.
• Rani Therapeutics — Rani is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes. We have developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replacesubcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, we have successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill capsule. Our development efforts have enabled us to construct an extensive intellectual property portfolio that we believe provides us a competitive advantage.
• Promethera Biosciences — Promethera® Biosciences is a biopharmaceutical company, spin-off of the Université Catholique de Louvain, that develops innovative treatments based on allogeneic adult stem cell technology.Promethera® Biosciences' mission is to discover, develop and commercialize cell therapy products to treat liver diseases in an innovative way usingallogenic progenitor cells from healthy human livers.Promethera® Biosciences develops two products based on a newly discovered and patented progenitor cell type: the human Adult Liver-Derived Mesenchymal Progenitor Cell (hALDMSC):

Portfolio highlights

• Odimma — Empowering personalized immunotherapy to treat cancer
• Braintale — Braintale develops and distributes accessible and effective diagnosis and prognosis tools for brain-injured patients.BrainTale’s products are based on medical needs understanding, fulfilling healthcare professionals and patients’ expectations, and is built upon more than 15 years of clinical development. The company was founded in 2018 and basedin Paris, France.
• Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.

Portfolio highlights

• ATAWEY — Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than asimple response: a solution that adapts to your uses.The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.
• Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
• Meccellis Biotech — Meccellis Biotech is a manufacturer of tissue and cell and biomaterials.

Portfolio highlights

• EasyPicky — Easypicky provides quick image identification technology that improves planogram control from any on-board system.
• Nimbl'bot — Nimbl'bot argues that robotics can help to protect the health of manual workers. Its robots are designed to handle the most time-consuming and risky activities, allowing humans to focus on higher-value duties.
• getfluence — Discover Getfluence, the global sponsored content marketplace, and make headlines on premium media. Buy and get your SEO backlinks today.

Portfolio highlights

• Famoco — Famoco provides an Enterprise Mobility Management (EMM) solution with a range of secure, remotely managed Android devices. Famoco offers...
• PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
• Evercontact — Let Evercontact connect the dots in your life by turning your emails into an always-updated address book!

Portfolio highlights

• Tridek-One — Tridek-One is a private biotechnology company founded in 2018, based on groundbreaking research by our scientific founders at INSERM, Paris on the role of CD31 in the modulation of the immune response.
• Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
• Bicara Therapeutics — Bicara enables access to the thriving innovation ecosystem which accelerates our development of therapies for cancer. Synergies between the Bicara teams in Boston and Bengaluru will pioneer breakthrough innovation.

Portfolio highlights

• Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
• Odimma — Empowering personalized immunotherapy to treat cancer
• Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.

Portfolio highlights

• EyeLights — EyeLights is a Head Up Display GPS. It allows motobikers to truly experience the ride by keeping their eyes on the road. Eyelights is the first universal motorcycle accessory that projects guidance, danger zones and traffic directly into your field of vision. A dangerous bend, a nearby stopper or speed over limitations, EyeLights warns you. Simple,uncluttered, they adapted the display for motorcycle riding.The EyeLights product installs in less than 5 minutes on your full-face, convertible or jet helmet. Their compact optical technology allows you to view your GPS more than 2 meters away while enjoying audio functions for more than 8 hours. The product is compatible with sun visors, insensitive to rain or fog and weighs less than 100g.
• Mistikist — Mistikist's AI Assisted Brainwave Entrainment for focus, relaxation & sleep. Well-being in just minutes with neuroscience backed methodology.
• Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.

Portfolio highlights

• Gentis — Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine. The company's patented product is DiscCell, an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc.Gentis wasfounded on 2000 and is headquartered in Wayne, Pennsylvania.
• Alveolus — Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.
• Arterial Remodeling Technologies — I found a great domain name for sale on Dan.com. Check it out!

Portfolio highlights

• Oreegami — Oreegami is a digital marketing academy that offers training to the future elite of digital marketing and data. It specializes in education, digital marketing, ESS, formation, search, Adwords, analytics, Programmatic, and Facebook ads.
• Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
• Le Mercato de l'Emploi — Le Mercato de l'Emploi is a local recruitment firm. The company aims to refocus the meeting between employers and job candidates on a human approach and proximity while taking advantage of the strengths of digital and social networks. Le Mercato de l'Emploi was established in 2017 in Salles-d'angles, France.

Portfolio highlights

• Mariana Oncology — Mariana Oncology is a biotechnology research industry.
• Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
• Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

Portfolio highlights

• VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
• Aura Biosciences — Aura Biosciences is pioneering a first-in-class technology to treat a wide variety of solid tumor types. We are initially pursuing cancers where patients are in need of a transformational change in treatment options, such as choroidal melanoma, so they can avoid choosing between preserving their life or their vision
• LEXEO Therapeutics — LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine. Beyond LEXEO Therapeutics’ lead programs – which are focused on both rare and non-rare monogenic (singlegenemutation) diseases – the company’s preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum of patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicine’s Department of Genetic Medicine to help advance the company’s pre-clinical pipeline.

Portfolio highlights

• ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
• Kalray — DPU processors, accelerator cards, software-defined storage and data management solutions for high-performance, data-centric computing.
• ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .

Portfolio highlights

• Advicenne — Specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan renal diseases and neurology.
• Millendo Therapeutics — Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
• Pixium Vision — Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that forblind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2.Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.

Portfolio highlights

• Vinidaily — Vinidaily is the application that helps you choose the wine 100% adapted to your tastes and the occasion, in your favorite supermarket and soon everywhere else.
• EuraTechnologies — EuraTechnologies promotes economic and social development through the exchange of scientific research and technologies. It is founded upon a principle of “technopolis”- a place dedicated to creating a vibrant synergy among research, superior education and technology.
• Meccellis Biotech — Meccellis Biotech is a manufacturer of tissue and cell and biomaterials.

Portfolio highlights

• ShowYou — They are developing the first digital solution dedicated to real estate developers for the management of acquisition modifying works (TMA). They created the first configurator in interactive plans allowing the customer to study his own modifications under the control of the promoter. With SHOW YOU: - save time - clarify and make the work morereliable - improve the satisfaction of your customers
• Reden Solar — Reden Solar develops, finances, builds, and operates solar photovoltaic power plants in Europe and Latin America with an installed portfolio of 762MW and a portfolio under development of 15GW. France and Spain are its main markets, and it has recently expanded its presence in Greece and Italy.
• Gunvor Group — Gunvor Group is one of the world’s largest independent commodities trading houses by turnover, creating logistics solutions that safely and efficiently move physical energy from where it is sourced and stored to where it is demanded most. With strategic investments in industrial infrastructure—refineries, pipelines, storage, terminals, mining andupstream—Gunvor further generates sustainable value across the global supply chain for its customers.

Portfolio highlights

• Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
• ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
• Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.

Portfolio highlights

• Vivalto Vie — Vivalto Vie is a privately held company that operates retirement homes in the Poitou-Charentes and Pays de la Loire regions.
• Airtel — Bharti Airtel Limited, commonly known as Airtel, is an Indian multinational telecommunications services company headquartered in New Delhi, India. It operates in 20 countries across South Asia, Africa, and the Channel Islands. Airtel has a GSM network in all countries in which it operates, providing 2G, 3G and 4G services depending upon the countryof operation.Airtel is the largest provider of mobile telephony and second largest provider of fixed telephony in India, and is also a provider of broadband and subscription television services. It offers its telecom services under the "airtel" brand, and is headed by Sunil Bharti Mittal. Bharti Airtel is the first Indian telecom service provider to achieve Cisco Gold certification. It also acts as a carrier for national and international long distance communication services. The company has a submarine cable landing station at Chennai, which connects the submarine cable connecting Chennai and Singapore.
• Les Opticiens Mobiles — Les Opticiens Mobiles is the first national network of opticians trained to intervene everywhere : at home, at work or in nursing homes or residences for elderly, both for working people and for fragile, isolated people.Covering the whole territory, the health professionals come to visit you with all the equipment needed. Based on an ethic chart,they offer services and products tailored to all : all types of glasses (eyeglasses, sunglasses, safety googles, contact lenses, hearing protection) with fixed prices, reimbursed by social welfare.

Portfolio highlights

• DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
• NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
• Bonum Therapeutics — Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.

Portfolio highlights

• HalioDx — Veracyte translates the tumor immune response into clear insights to guide treatment decisions, inform biomarker development, or advance therapeutics.
• Cintoo — Cintoo is essential for BIM to bridge the gap between your physical and virtual worlds.
• Keep Cool — Keep Cool is a operator of a chain of fitness centers.

Portfolio highlights

• BMI System — BMI System is a management software editor for the pharmaceutical, medical, and cosmetics industries The company exports its software packages to Europe and America. With the NAYA Compliance application it has established itself as the leading French company for regulatory compliance software for the pharmaceutical industry.

Portfolio highlights

• Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
• Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
• My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.

Portfolio highlights

• Algama — Algama harvests the potential of algae to create food that's good for both people and the planet.

Portfolio highlights

• Binalyze — Binalyze enhances all your digital forensics and incident response processes at max speed.
• ColibrITD — Quantum Computing Software Algorithm
• Re-Fresh Global — Re-Fresh Global brings sustainability innovation into the manufacturing industry. Our patented biotechnology transforms textile waste into recycled raw materials: nanocellulose, ethanol, and sanitized textile pulp.